Request Your Free Special Report Now:

"5 Trends of Rewriting the Rules of R&D Labs"

R&D budgets are tightening in many industries, ranging from automotive to biopharma and universities. To learn more, download this R&D World special report.

Biopharma R&D efficiency has ticked up, the overall drug approval odds have fallen to 6.7% from 10% a decade ago. But at the same time, new cost‑saving technologies are emerging that make discovery more capital‑efficient and data‑driven.

Offered Free by: Maxon
See All Resources from: Maxon